Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, find our latest releases and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample.
Nightingale Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases.
Contact us
ir@nightingalehealth.com
Latest releases
Nightingale Health's disease risk detection becomes available in Latvia through Professor Skride's Heart Clinic
Conversion of Nightingale Health Plc’s Series A shares to Series B shares
Nightingale Health's Remote Health Check becomes part of Coronaria's new weight management service in Finland
Nightingale Health Plc Financial Statements Release 1 July 2025 – 30 June 2026
Nightingale Health and Genom partner to bring blood-based risk detection to clinics and laboratories across Croatia
US healthcare commercial leader Hugh Watson joins Nightingale Health as Chief Commercial Officer, Americas
Nightingale Health and Supernormal partner to bring at-home blood testing to medical weight loss in Finland
Nightingale Health and Personalised Health Clinics collaborate on preventive metabolic health in the UK
Nightingale Health’s Board of Directors resolved on new stock option program
Subscribe to releases.
Get the latest Nightingale Health releases delivered straight to your inbox.